Cannabis consumption is a complex issue and is first and
foremost a health matter. While it is forbidden in France for
recreational or medical use, on October 25, 2019 the French
Parliament (National Assembly) gave its consent to conduct an
experimentation on medical use of cannabis starting in early
2020.
The French National Agency for Safety of the Medicinal products
(ANSM) had already approved the initiative in July 2019, in
addition to 17 others EU Member States.
The experimentation is scheduled to last two years, including a
6-month phase-in period, a 6-month inclusion period to enroll
patients, a 6-month period for patients monitoring and a 6-month
period of data analysis. A final report will then be established
and released by a scientific committee.